Schizophrenia genetics: advancing on two fronts

Current Opinion in Genetics and Development

Volumn 19, Issue 3, 2009, Pages 266-270

  Owen, Michael J ^a   Williams, Hywel J ^a   O'Donovan, Michael C ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; NEUREXIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 804A;

BEHAVIOR GENETICS; CHROMOSOME 15Q; CHROMOSOME 1Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HERITABILITY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 68649105951     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2009.02.008     Document Type: Review

References (29)

1. McGrath J.J. The surprisingly rich contours of schizophrenia epidemiology. Arch Gen Psychiatry 64 1 (2007) 14-16
2. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122 Pt 4 (1999) 593-624
3. Cardno A.G., and Gottesman I.I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97 1 (2000) 12-17
4. Wang W.Y., Barratt B.J., Clayton D.G., and Todd J.A. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 6 2 (2005) 109-118
5. Craddock N., O'Donovan M.C., and Owen M.J. Phenotypic and genetic complexity of psychosis. Invited commentary on schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry 190 (2007) 200-203
6. Ross C.A., Margolis R.L., Reading S.A., Pletnikov M., and Coyle J.T. Neurobiology of schizophrenia. Neuron 52 1 (2006) 139-153
7. Manolio T.A., Brooks L.D., and Collins F.S. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118 5 (2008) 1590-1605
8. The International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 449 7164 (2007) 851-861
9. Lencz T., Morgan T.V., Athanasiou M., Dain B., Reed C.R., Kane J.M., Kucherlapati R., and Malhotra A.K. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 12 6 (2007) 572-580
10. Sullivan P.F., Lin D., Tzeng J.Y., van den Oord E., Perkins D., Stroup T.S., Wagner M., Lee S., Wright F.A., Zou F., et al. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry 13 6 (2008) 570-584
11. Dudbridge F., and Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32 3 (2008) 227-234
12. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40 (2008) 1053-1055. Using a GWAs design and follow-up in 6829 cases and 9897 controls, the authors obtain support for three loci the best supported of which was in the vicinity of a putative transcription regulator (zinc finger protein 804A or ZNF804A). This study establishes the principle that relatively common risk alleles for schizophrenia exist notwithstanding the low fecundity seen in this disorder.
13. Craddock N., O'Donovan M.C., and Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 32 1 (2006) 9-16
14. Mah S., Nelson M.R., Delisi L.E., Reneland R.H., Markward N., James M.R., Nyholt D.R., Hayward N., Handoko H., Mowry B., et al. Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. Mol Psychiatry 11 5 (2006) 471-478
15. Kirov G., Zaharieva I., Georgieva L., Moskvina V., Nikolov I., Cichon S., Hillmer A., Toncheva D., Owen M.J., and O'Donovan M.C. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol Psychiatry (2008) 10.1038/mp.2008.33
16. Shifman S., Johannesson M., Bronstein M., Chen S.X., Collier D.A., Craddock N.J., Kendler K.S., Li T., O'Donovan M., O'Neill F.A., et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 4 2 (2008) e28
17. Hong S.E., Shugart Y.Y., Huang D.T., Shahwan S.A., Grant P.E., Hourihane J.O., Martin N.D., and Walsh C.A. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet 26 1 (2000) 93-96
18. Craddock N., O'Donovan M.C., and Owen M.J. Genome-wide association studies in psychiatry: lessons from early studies of non-psychiatric and psychiatric phenotypes. Mol Psychiatry 13 7 (2008) 649-653
19. McCarroll S.A., Kuruvilla F.G., Korn J.M., Cawley S., Nemesh J., Wysoker A., Shapero M.H., de Bakker P.I., Maller J.B., Kirby A., et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 40 10 (2008) 1166-1174
20. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., Yamrom B., Yoon S., Krasnitz A., Kendall J., et al. Strong association of de novo copy number mutations with autism. Science 316 5823 (2007) 445-449
21. Autism Genome Project Consortium. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39 3 (2007) 319-328
22. Murphy K.C., Jones L.A., and Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56 10 (1999) 940-945
23. Kirov G., Gumus D., Chen W., Norton N., Georgieva L., Sari M., O'Donovan M.C., Erdogan F., Owen M.J., Ropers H.H., et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 17 3 (2008) 458-465. Early study using complete genome hybridisation implicates CNVs involving NRX1 and APBA2 in schizophrenia.
24. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320 5875 (2008) 539-543. CGH study of schizophrenia. First study implicates increased burden of CNVs in schizophrenia.
25. Rujescu D., Ingason A., Cichon S., Pietilainen O.P., Barnes M.R., Toulopoulou T., Picchioni M., Vassos E., Ettinger U., Bramon E., et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 10.1093/hmg/ddn351. Analysis of oligonucleotide array data confirms that deletions disrupting NRXN1 confer risk of schizophrenia.
26. Xu B., Roos J.L., Levy S., van Rensburg E.J., Gogos J.A., and Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 40 7 (2008) 880-885. This study demonstrates the increased rate of de novo CNVs in sporadic schizophrenia.
27. ••].
28. ••] this paper analyses the oligonucleotide array data from large sample of cases and controls and provides evidence both for an increased burden of CNVs in schizophrenia and that risk is conferred by specific large deletions at 1q21.1 and at 15q13.2.
29. Mefford H.C., Sharp A.J., Baker C., Itsara A., Jiang Z., Buysse K., Huang S., Maloney V.K., Crolla J.A., Baralle D., et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 359 16 (2008) 1685-1699. Clinical study of large sample of patients referred for screening suggests CNVs at the 1q21.1 locus are associated with microcephaly, various physical abnormalities and neuro-developmental abnormalities including MR, autism and ADHD.